CRISPR-Cas systems in diagnostics: A comprehensive assessment of Cas effectors and biosensors
Gene and Genome Editing · 2022
DOI: 10.1016/j.ggedit.2022.100019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene and Genome Editing, 2022. Verfasst von Reha Onur Azizoglu. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: TÜBİTAK.
Abstract (Originalsprache)
The development of rapid, sensitive, specific and accurate diagnostic tests is essential for improving the treatment outcome of diseases. In the majority of disease diagnosis, nucleic acid-based tests are accepted as a gold standard. In general, these tests provide reliable results, yet they require highly trained personnel and specialized equipmentation. With the introduction of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas systems in diagnostic applications, achieving breakthrough improvements in diagnostic tests is now possible. The specific target sequence recognition ability and trans-cleavage activity of certain Cas proteins enable novel applications of these systems in the development and improvement of diagnostic tests. These improvements and innovations allow for improved sensitivity, specificity and accuracy of point-of-care tests while keeping their costs at affordable levels. In this review, a comprehensive analysis of the common CRISPR-Cas systems used in diagnostic applications and the utilization of these systems in the design of novel biosensors is provided.
Förderung
- TÜBİTAK
Zitieren
APA
Azizoglu, R. O. (2022). CRISPR-Cas systems in diagnostics: A comprehensive assessment of Cas effectors and biosensors. Gene and Genome Editing. https://doi.org/10.1016/j.ggedit.2022.100019
Vancouver
Azizoglu RO. CRISPR-Cas systems in diagnostics: A comprehensive assessment of Cas effectors and biosensors. Gene and Genome Editing. 2022. doi:10.1016/j.ggedit.2022.100019
BibTeX
@article{Azizoglu2022,
author = {Azizoglu, Reha Onur},
title = {CRISPR-Cas systems in diagnostics: A comprehensive assessment of Cas effectors and biosensors},
journal = {Gene and Genome Editing},
year = {2022},
doi = {10.1016/j.ggedit.2022.100019}
}
EUVIMED